🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10,225 results for “He” Clear

  1. TBPM-PI-HBr

    Spero Therapeutics

    Complicated Urinary Tract Infection

    phase 3 small molecule completed

    1 trial

  2. TD-1473 Dose A

    Theravance Biopharma Ireland Umited

    Ulcerative Colitis (UC)

    phase 3 small molecule terminated

    2 trials

  3. TD-4208

    Theravance Biopharma Ireland Umited

    Chronic Obstructive Pulmonary Disease (COPD)

    phase 3 small molecule completed

    4 trials

  4. TDV

    Takeda

    Healthy Volunteers

    phase 3 mab completed

    4 trials

  5. TENOFOVIR DISOPROXIL , ENTECAVIR , VAY736, -, Placebo to VAY736 150 mg/1 mL Solution for injection in pre-filled syringe, TENOFOVIR ALAFENAMIDE

    Novartis Pharmaceuticals

    Systemic Lupus Erythematosus

    phase 3 small molecule active

    1 trial

  6. TETRACOSACTIDE , BETAMETHASONE , Placebo of fludrocortisone, Placebo of hydrocortisone hemisuccinate, FLUDROCORTISONE , HYDROCORTISONE HEMISUCCINATE

    Pari Pharma GmbH

    Critically ill patients suffering from CIRCI

    phase 3 small molecule active

    1 trial

  7. TIRBANIBULIN, Placebo of the new presentation of 350 mg/sachet drug product (hereafter referred as vehicle) is a smooth, creamy white to off-white ointment free from foreign particles, packed intact and properly sealed containing the same qualitative composition as the active product but without the active substance. The vehicle will be provided in a single-use packets to contain 350 mg of drug product., Klisyri 10 mg/g ointment

    Almirall, S.A.

    Actinic Keratosis on the Face or Scalp

    phase 3 small molecule active

    1 trial

  8. TKI

    United Therapeutics Europe Ltd

    NSCLC

    phase 3 small molecule active

    1 trial

  9. TNK-tPA

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    phase 3 small molecule active

    1 trial

  10. TNX-103

    TENAX THERAPEUTICS, INC.

    Pulmonary Hypertension

    phase 3 small molecule active

    1 trial

  11. TNX-103

    TENAX THERAPEUTICS, INC.

    Pulmonary Hypertension Associated With HFpEF

    phase 3 small molecule active

    2 trials

  12. TOOKAD 183 mg powder for solution for injection, PADELIPORFIN

    STEBA Biotech S.A

    Low Grade Upper Tract Urothelial Cancer

    phase 3 small molecule active

    1 trial

  13. TOPOTECAN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE, PACLITAXEL, KEYTRUDA 25 mg/mL concentrate for solution for infusion, NEMVALEUKIN ALFA, GEMCITABINE HYDROCHLORIDE, TOPOTECAN HYDROCHLORIDE

    Wuhan Createrna Science and Technology Co., Ltd

    Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    phase 3 small molecule active

    1 trial

  14. TPOXX

    United Therapeutics Europe Ltd

    Smallpox

    phase 3 small molecule completed

    1 trial

  15. TPST-1120

    Tempest Therapeutics

    Hepatocellular Carcinoma (HCC)

    phase 3 small molecule active

    1 trial

  16. TQJ230

    Novartis Pharmaceuticals

    Atherosclerotic cardiovascular disease (ASCVD)

    phase 3 small molecule active

    1 trial

  17. TQJ230, INCLISIRAN, Placebo to TQJ230 80 mg/0.8 mL Solution for injection in pre-filled syringe with needle safety device

    Novartis Pharmaceuticals

    Atherosclerotic cardiovascular disease (ASCVD)

    phase 3 small molecule active

    1 trial

  18. TQJ230, Placebo to TQJ230 80 mg/0.8 mL Solution for injection in pre-filled syringe with needle safety device

    Novartis Pharmaceuticals

    Apheresis

    phase 3 small molecule active

    1 trial

  19. TRIAMCINOLONE , VANCOMYCIN , CEFAZOLIN , BETAMETHASONE , OMEPRAZOLE , JNJ-74765340, JNJ-74765340, DEXAMETHASONE , CEFUROXIME

    Janssen-Cilag International N.V.

    X-Linked Retinitis Pigmentosa caused by mutations in the RPGR gene

    phase 3 small molecule active

    1 trial

  20. TRIGON DEPOT 40 mg/ml suspensión inyectable.

    The George Institute

    Chronic shoulder pain

    phase 3 small molecule active

    1 trial

  21. TROMALYT 150 mg cápsulas duras de liberación prolongada

    The George Institute

    Women infertility

    phase 3 small molecule active

    1 trial

  22. TROPICAMIDE, Vehicle for cenegermin drug product, COLIROFTA ANESTÉSICO DOBLE 1 MG/ML + 4 MG/ML COLIRIO EN SOLUCIÓN, OXERVATE 20 micrograms/ml eye drops, solution

    Dompe' Farmaceutici S.p.A.

    Persistent Corneal Epithelial Defect (PCED)

    phase 3 small molecule active

    1 trial

  23. TRUQAP 160 mg film-coated tablets, Fulvestrant Dr. Reddy’s 250 mg Solution For Injection in Pre-Filled Syringe, RLY-2608, Fulvestrant EVER Pharma 250 mg solution for injection in pre-filled syringe, Fulvestrant Dr. Reddys 250 mg solución inyectable en jeringa precargada EFG, TRUQAP 200 mg film-coated tablets

    Relay Therapeutics

    PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer

    phase 3 small molecule active

    1 trial

  24. TRUQAP 160 mg film-coated tablets, TRUQAP 200 mg film-coated tablets

    AstraZeneca

    HR+ / HER2- advanced breast cancer

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources